Driving innovation in advanced therapies 24/02/2025 Healthcare Access to innovation Innovative drugs Personalized medicine To contribute to the democratization of access to new cell therapies, Klinea works on various initiatives. The project... Partners - Klinea Biotech & Pharma Engineering
AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagno... 20/02/2025 Healthcare Access to innovation Innovative drugs We trust that this decision will help reduce the bottleneck caused by the high demand for certification under the new... AseBio
AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagno... 20/02/2025 It joins the other 13 European entities authorized to assess the compliance of these products before they reach the... AseBio
FARMAFORUM Pabellón 9-IFEMA (MADRID) España Del 17/09/2025 to 18/08/2025 Healthcare Access to innovation International
ON Helix Cambridge United Kingdom Del 03/07/2025 to 03/07/2025 Healthcare Access to innovation International
AseBio advocates for collaboration and technology transfer as drivers of the biotechnology... 06/02/2025 Healthcare Access to innovation Agrifood Industrial biotechnology Financing Talento Biotechnological innovation is based on technology transfer and collaboration among the various players in the ecosystem... AseBio
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non... AseBio - BATEA ONCOLOGY S.L.
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 BATEA ONCOLOGY S.L. It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments... AseBio - BATEA ONCOLOGY S.L.
Integra Therapeutics part of Spanish Government presentation of ‘HispanIA 2040’ as an AI f... 28/01/2025 Healthcare Access to innovation Personalized medicine Gene editing HispanIA 2040 is a strategic study promoted by the Spanish National Office of Foresight and Strategy, compiled by 12... Partners - Integra Therapeutics S.L.
